Aarhus University Seal

Dansk

You are here: » Thomas A. Rasmussen » Research outputs

About Aarhus University

Thomas A. Rasmussen

1 - 71 out of 71Page size: 100
RSS feed of this list
  1. 2023
  2. Published
    Experience with Sotrovimab treatment of SARS-CoV-2 infected patients in Denmark. / Rasmussen, Line Dahlerup; Lebech, Anne-Mette; Øvrehus, Anne et al.
    In: British Journal of Clinical Pharmacology, Vol. 89, No. 6, 06.2023, p. 1820-1833.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  3. Published
    Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy. / Chiu, Chris Y.; Schou, Maya D.; McMahon, James H. et al.
    In: Frontiers in Immunology, Vol. 14, 1123342, 03.2023.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  4. 2022
  5. Published
    Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size. / Rasmussen, Thomas A.; Ahuja, Sunil K.; Kuwanda, Locadiah et al.
    In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, No. 10, 11.2022, p. 1781-1791.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  6. Published
    Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency. / Rasmussen, Thomas A.; Zerbato, Jennifer M.; Rhodes, Ajantha et al.
    In: Cell Reports Medicine, Vol. 3, No. 10, 100766, 18.10.2022.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  7. Published
    Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). / Rawat, Priyank; Zerbato, Jennifer M; Rhodes, Ajantha et al.
    In: Pathology, Vol. 54, No. 5, 08.2022, p. 623-628.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  8. Published
    Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design. / Lau, Jillian S Y; Cromer, Deborah; Pinkevych, Mykola et al.
    In: The Journal of Infectious Diseases, Vol. 226, No. 2, 07.2022, p. 236-245.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  9. Published
    Immune checkpoint blockade in HIV. / Gubser, Celine; Chiu, Chris; Lewin, Sharon R. et al.
    In: EBioMedicine, Vol. 76, 103840, 02.2022.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

  10. Published
    Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy. / Chiu, Chris Y; Chang, Judy J; Dantanarayana, Ashanti I et al.
    In: Journal of Immunology, Vol. 208, No. 1, 01.01.2022, p. 54-62.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  11. Published
    Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. / McMahon, James H; Evans, Vanessa A; Lau, Jillian S Y et al.
    In: AIDS, Vol. 36, No. 1, 01.01.2022, p. 75-82.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  12. Published
    Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy. / Uldrick, Thomas S.; Adams, Scott V.; Fromentin, Remi et al.
    In: Science Translational Medicine, Vol. 14, No. 629, eabl3836, 01.2022.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  13. 2021
  14. Published
    Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound. / Corley, Michael J.; Pang, Alina P.S.; Rasmussen, Thomas A. et al.
    In: AIDS, Vol. 35, No. 14, 15.11.2021, p. 2269-2279.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  15. Published
    Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study. / Rasmussen, Thomas A; Rajdev, Lakshmi; Rhodes, Ajantha et al.
    In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, No. 7, 05.10.2021, p. e1973-e1981.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  16. Published
    Viral, inflammatory, and reservoir characteristics of posttreatment controllers. / McMahon, James; Lewin, Sharon R.; Rasmussen, Thomas A.
    In: Current Opinion in HIV and AIDS, Vol. 16, No. 5, 09.2021, p. 249-256.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  17. Published
    The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy. / Lau, Jillian S Y; McMahon, James H; Gubser, Celine et al.
    In: AIDS, Vol. 35, No. 10, 01.08.2021, p. 1631-1636.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  18. Published
    Toll-like Receptor 7 Agonists in People Living With HIV: Implications for Immunotherapeutic Strategies for an HIV Cure. / Rasmussen, Thomas A; Lewin, Sharon R.
    In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, No. 11, 01.06.2021, p. e825-e827.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Communication

  19. Published
    Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium. / Rokx, C.; Prins, Henrieke; Vandekerckhove, L. et al.
    In: Journal of virus eradication, Vol. 7, No. 2, 100045, 06.2021.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  20. Published
    A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls. / McMahon, James H; Zerbato, Jennifer M; Lau, Jillian S Y et al.
    In: EBioMedicine, Vol. 65, 103252, 03.2021, p. 103252.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  21. Published
    Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings. / Lau, Jillian Sy; Rasmussen, Thomas A; Lewin, Sharon R et al.
    In: Journal of virus eradication, Vol. 7, No. 1, 100032, 03.2021, p. 100032.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  22. Published
    Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency. / Zerbato, Jennifer M; Khoury, Georges; Zhao, Wei et al.
    In: EBioMedicine, Vol. 65, 103241, 03.2021, p. 103241.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  23. 2020
  24. Published
    HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. / Offersen, Rasmus; Yu, Wen Han; Scully, Eileen P. et al.
    In: Cell Reports, Vol. 33, No. 11, 108502, 12.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  25. Published
    Managing HIV-associated inflammation and ageing in the era of modern ART. / Bloch, M; John, M; Smith, D et al.
    In: HIV Medicine, Vol. 21 Suppl 3, No. S3, 10.2020, p. 2-16.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

  26. Published
    Kick and kill for HIV latency. / Lewin, Sharon R; Rasmussen, Thomas A.
    In: Lancet, Vol. 395, No. 10227, 14.03.2020, p. 844-846.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Communication

  27. 2019
  28. Published
    Between a shock and a hard place: challenges and developments in HIV latency reversal. / Zerbato, Jennifer M; Purves, Harrison V; Lewin, Sharon R et al.
    In: Current Opinion in Virology, Vol. 38, 10.2019, p. 1-9.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

  29. Published
    In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals. / Garrido, Carolina; Tolstrup, Martin; Søgaard, Ole S. et al.
    In: AIDS (London, England), Vol. 33, No. 4, 03.2019, p. 605-613.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  30. Published
    Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation. / Damsgaard Gunst, Jesper; Kjær, Kathrine; Olesen, Rikke et al.
    In: Journal of virus eradication, Vol. 5, No. 3, 2019, p. e1-e5.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  31. 2018
  32. Published
    The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. / Rasmussen, Thomas A.; McMahon, James H.; Chang, J. Judy et al.
    In: The Lancet HIV, Vol. 5, No. 5, 01.05.2018, p. e221-e230.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  33. Published
    Patient-reported outcomes in daily clinical practise in HIV outpatient care. / Kjær, Anne Sofie Høgh Kølbæk; Rasmussen, Thomas Aagaard; Hjollund, Niels Henrik et al.
    In: International Journal of Infectious Diseases, Vol. 69, 04.2018, p. 108-114.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  34. Published
    Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Lipopolysaccharide-Induced Inflammatory Responses. / Brinkmann, Christel Rothe; Højen, Jesper Falkesgaard; Rasmussen, Thomas Aagaard et al.
    In: mSphere, Vol. 3, No. 1, e00616-17, 23.02.2018.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  35. Published
    Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency. / Pinkevych, Mykola; Fennessey, Christine M; Cromer, Deborah et al.
    In: Journal of Virology, Vol. 92, No. 2, e01667-17, 15.01.2018.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  36. Published
    Clinical Interventions in HIV Cure Research. / Rasmussen, Thomas Aagaard; Søgaard, Ole S.
    In: Advances in Experimental Medicine and Biology, Vol. 1075, 2018, p. 285-318.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  37. Published
    The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. / Krarup, A R; Abdel-Mohsen, M; Schleimann, M H et al.
    In: Mucosal Immunology, Vol. 11, No. 2, 2018, p. 449–461.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  38. 2017
  39. Published
    Modelling of anti-latency treatment in HIV; What is the optimal duration of anti-retroviral-free HIV remission? / Cromer, Deborah; Pinkevych, Mykola; Rasmussen, Thomas A et al.
    In: Journal of Virology, Vol. 91, No. 24, e01395-17, 11.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  40. Published
    Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. / Rasmussen, Thomas A; McMahon, James; Chang, J Judy et al.
    In: AIDS, Vol. 31, No. 13, 24.08.2017, p. 1839-1845.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  41. Published
    HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal. / Wu, Guoxin; Swanson, Michael; Talla, Aarthi et al.
    In: JCI Insight, Vol. 2, No. 16, e92901, 17.08.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  42. Published
    Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption. / Lee, Wen Shi; Kristensen, Anne B; Rasmussen, Thomas A et al.
    In: Journal of Virology, Vol. 91, No. 15, e00603-17, 07.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  43. Published
    Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in three HIV infected individuals. / Koelsch, Kersten K; Rasmussen, T A; Hey-Nguyen, W J et al.
    In: J A I D S, Vol. 75, No. 3, 07.2017, p. 328-337.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  44. Published
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection. / Vibholm, Line; Schleimann, Mariane H; Højen, Jesper F et al.
    In: Clinical Infectious Diseases, 15.06.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  45. Published
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy. / Mota, Talia M; Rasmussen, Thomas A; Rhodes, Ajantha et al.
    In: AIDS, Vol. 31, No. 8, 05.2017, p. 1137-1141.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  46. Published
    Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents. / Petravic, Janka; Rasmussen, Thomas A; Lewin, Sharon R et al.
    In: Journal of Virology, Vol. 91, No. 9, e02092-16, 04.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  47. Published
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. / Winckelmann, Anni; Barton, Kirston; Hiener, Bonnie et al.
    In: AIDS, Vol. 31, No. 6, 27.03.2017, p. 771-779.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  48. Published
    A5 Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin. / Winckelmann, A; Barton, K; Hiener, B et al.
    In: Virus evolution, Vol. 3, No. Suppl 1, A5, 03.2017.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

  49. 2016
  50. Published
    Cancer therapies in HIV cure research. / Rasmussen, Thomas A; Anderson, Jenny L; Wightman, Fiona et al.
    In: Current Opinion in HIV and AIDS, Vol. 12, No. 1, 07.09.2016, p. 96-104.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  51. Published
    Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission. / Pinkevych, Mykola; Cromer, Deborah; Tolstrup, Martin et al.
    In: P L o S Pathogens, Vol. 12, No. 8, 08.2016, p. e1005745.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  52. Published
    Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days. / Pinkevych, Mykola; Kent, Stephen J; Tolstrup, Martin et al.
    In: P L o S Pathogens, Vol. 12, No. 8, e1005740, 08.2016, p. e1005740.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  53. Published
    Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial. / Leth, Steffen; Schleimann, Mariane Høgsbjerg; Nissen, Sara K et al.
    In: Lancet HIV, Vol. 3, No. 10, 07.07.2016, p. e463–e472.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  54. Published
    Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents? / Rasmussen, Thomas A; Lewin, Sharon R.
    In: Current Opinion in HIV and AIDS, Vol. 11, No. 4, 07.2016, p. 394-401.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  55. Published
    The potential role for romidepsin as a component in early HIV-1 curative efforts. / Damsgaard Gunst, Jesper; Tolstrup, Martin; Rasmussen, Thomas Aagaard et al.
    In: Expert Review of Anti-infective Therapy, Vol. 14, No. 5, 05.2016, p. 447-50.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  56. Published
    A novel toll-like receptor-9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1 infected autologous CD4+ T cells. / Offersen, Rasmus; Nissen, Sara Konstantin; Rasmussen, Thomas Aagaard et al.
    In: Journal of Virology, Vol. 90, No. 9, 17.02.2016, p. 4441-4453.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  57. Published
    Reversal of Latency as Part of a Cure for HIV-1. / Rasmussen, Thomas Aagaard; Tolstrup, Martin; Søgaard, Ole Schmeltz.
    In: Trends in Microbiology, Vol. 24, No. 2, 02.2016, p. 90-7.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  58. Published
    Ethics of ART interruption after stem-cell transplantation. / Sugarman, Jeremy; Lewin, Sharon R; Henrich, Timothy J et al.
    In: Lancet HIV, Vol. 3, No. 1, 01.2016, p. e8-10.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  59. Published
    Broad activation of latent HIV-1 in vivo. / Barton, Kirston; Hiener, Bonnie; Winckelmann, Anni et al.
    In: Nature Communications, Vol. 7, 12731, 2016, p. 12731.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  60. Published
    HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy. / Leth, Steffen; Nymann, Rasmus; Jorgensen, Sofie et al.
    In: AIDS, Vol. 30, No. 5, 2016, p. 713-721.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  61. 2015
  62. Published
    Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. / Olesen, Rikke; Vigano, Selena; Rasmussen, Thomas A et al.
    In: Journal of Virology, Vol. 89, No. 20, 10.2015, p. 10176-89.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  63. Published
    HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission. / Pinkevych, Mykola; Cromer, Deborah; Tolstrup, Martin et al.
    In: P L o S Pathogens, Vol. 11, No. 7, 07.2015, p. e1005000.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  64. Published
    Interleukin-37 expression is increased in chronic HIV-1-infected individuals and is associated with inflammation and the size of the total viral reservoir. / Hansen, Jesper Falkesgaard; Rasmussen, Thomas A; Andersen, Karen Lise D et al.
    In: Molecular Medicine, 14.04.2015.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  65. Published
    The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients. / Høgh Kølbæk Kjær, Anne Sofie; Brinkmann, Christel Rothe; Dinarello, Charles A et al.
    In: AIDS, 13.04.2015.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  66. Published
    Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system. / Rasmussen, Thomas A; Tolstrup, Martin; Møller, Holger Jon et al.
    In: Open Forum Infectious Diseases, Vol. 2, No. 1, 01.2015, p. ofv037.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  67. Published
    Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. / Bjerg Christensen, Ane; Dige, Anders; Vad-Nielsen, Johan et al.
    In: Mediators of Inflammation, Vol. 2015, 120605, 2015.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  68. Published
    Histone Deacetylase Inhibitor Romidepsin Inhibits de novo HIV-1 Infections. / Jønsson, Kasper L; Tolstrup, Martin; Vad-Nielsen, Johan et al.
    In: Antimicrobial Agents and Chemotherapy, Vol. 59, No. 7, 2015, p. 3984-3994.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  69. Published
    The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. / Søgaard, Ole S; Graversen, Mette E; Leth, Steffen et al.
    In: P L o S Pathogens, Vol. 11, No. 9, e1005142, 2015, p. 1-22.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  70. 2014
  71. Published
    Reversal of HIV-1 Latency by Histone Deacetylase Inhibitors: Part of an HIV-1 Curative Strategy? / Rasmussen, Thomas Aagaard.
    Fællestrykkeriet for Sundhedsvidenskab, Aarhus Universitet, 2014.

    Research output: Book/anthology/dissertation/report › Ph.D. thesis

  72. Published
    Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. / Rasmussen, Thomas A; Tolstrup, Martin; Brinkmann, Christel R et al.
    In: Lancet, Vol. 1, No. 1, 10.2014, p. e13-21.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  73. 2013
  74. Published
    Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials. / Rasmussen, Thomas Aagaard; Tolstrup, Martin; Winckelmann, Anni et al.
    In: Human Vaccines & Immunotherapeutics, Vol. 9, No. 4, 01.04.2013.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  75. Published
    Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation. / Rasmussen, Thomas Aagaard; Schmeltz Søgaard, Ole; Brinkmann, Christel et al.
    In: Human Vaccines & Immunotherapeutics, Vol. 9, No. 5, 31.01.2013, p. 993-1001.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  76. Published
    Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients. / Winckelmann, Anni A; Munk-Petersen, Lærke V; Rasmussen, Thomas A et al.
    In: P L o S One, Vol. 8, No. 4, 2013, p. e62074.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  77. 2012
  78. Published
    Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial. / Rasmussen, Thomas A; Jensen, Danny; Tolstrup, Martin et al.
    In: P L o S One, Vol. 7, No. 3, e32445, 2012.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  79. Published
    Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study. / Rasmussen, Thomas Aagaard; Jørgensen, Martin; Bjerrum, Stephanie et al.
    In: B M J, Vol. 345, 2012, p. e5823.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  80. 2011
  81. Published
    Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy. / Rasmussen, Thomas Aagaard; Tolstrup, Martin; Melchjorsen, Jesper et al.
    In: B M C Infectious Diseases, Vol. 11, 2011, p. 267.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  82. Published
    Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir. / Matalon, Shay; Rasmussen, Thomas A; Dinarello, Charles A.
    In: Molecular Medicine, Vol. 17, No. 5-6, 2011, p. 466-472.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  83. Published
    Serum procalcitonin in pulmonary tuberculosis. / Rasmussen, T A; Søgaard, O S; Camara, C et al.
    In: International Journal of Tuberculosis and Lung Disease, Vol. 15, No. 2, 2011, p. 251-6, i.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  84. 2010
  85. Published
    Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapy. / Søgaard, Ole S; Schønheyder, Henrik C; Bukh, Anne R et al.
    In: AIDS, Vol. 24, No. 9, 2010, p. 1315-22.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review